1 / 116

Lecturer name: Osama Ibraheim MD,SOB. Lecture date:

Lecture Title: Acute Pain Management. Lecturer name: Osama Ibraheim MD,SOB. Lecture date:. Lecture Objectives. Fundamental Considerations. Millions of patients worldwide undergo surgery.

Download Presentation

Lecturer name: Osama Ibraheim MD,SOB. Lecture date:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lecture Title: Acute Pain Management Lecturer name:Osama Ibraheim MD,SOB. Lecture date:

  2. Lecture Objectives..

  3. Fundamental Considerations • Millions of patients worldwide undergo surgery. Although developing more effective techniques for postoperative analgesia, many patients experience pain.

  4. PAIN An unpleasant sensory and emotional experience associated with actual or potential tissue damage. IASP, Subcommittee on Taxonomy, 1979

  5. ETIOLGY OF PAIN • HEAT • COLD • CHEMICAL • MECHANICAL TORSION STRETCH CUT PINCH PRICK COMPRESS CRUSH

  6. TYPOLOGY OF PAIN • Acute • Chronic benign • Chronic cancer

  7. Chronic Pain vs Acute Pain Acute: A Symptom of Injury or Disease Chronic Benign: Pain itself is the disease Chronic Cancer: Actual Tissue destruction

  8. Adverse Effects of Pain • Cardiovascular • Pulmonary • Gastrointestinal • Renal • Extremities • Endocrine • CNS • Immunologic

  9. Adverse Effects of Pain Cardiovascular: Tachycardia, hypertension, increased SVR, increased cardiac work, increased myocardial O2 demand. Pulmonary: Hypoxia, hypercarbia, atelectasis, decreased cough, decreased vital capacity and function residual capacity, V/Q mismatch. Gastrointestinal: Nausea, vomiting, ileus, intolerance for oral intake. Renal: Oliguria, urinary retention.

  10. Adverse Effects of Pain Extremities: Skeletal muscle spasm, limited mobility, thromboembolism. Endocrine: Excessive adrenergic activity, vagal inhibition, catabolic metabolism, increased O2 consumption. CNS: Sedation, fatigue, anxiety, and fear cause central sympathetic stimulation. Immunologic: Inhibited cellular immunity, increased risk of infection, ?? impaired wound healing ??

  11. FREE NERVE ENDINGS ARE PRESENT IN ESSENTIALLY ALL BODY TISSUES IN VARYING AMOUNTS

  12. IN RESPONSE TO A PAINFUL STIMULUS, SUBSTANCES ARE EXCRETED.

  13. ALGOGENIC(substances released by pain) SEROTONIN POTASSIUM HISTAMINE ACETLYCHOLINE BRADYKININS LEUKOTRIENES PROSTAGLANDINS SUBSTANCE P29 NOREPINEPHRINE

  14. THE RECEPTORS IN THE FREE NERVE ENDINGS RESPOND TO THE SUBSTANCES BY BECOMING CHARGED ELECTROCHEMICALY

  15. RECEPTORS THEN PROPAGATE AN ELECTROCHEMICAL STIMULUS TO DIFFERING NERVE FIBERS

  16. NOCICEPTION This electrochemical event that occurs between the site of tissue damage or injury sets off a series of neural transmissions that eventually results in the perception of pain……Collectively this known as nociception

  17. NERVE FIBERPAIN CLASSIFICATION A FIBER……..SHARP-STABBING-LOCAL “ FIRST PAIN” B FIBER....PHYSIOLOGIAL REACTION C FIBER....DULL-ACHE-BURN-THROB NONLOCALIZED-RADIATE “SECOND PAIN”

  18. NERVE FIBER CLASSIFCATION TYPE FUNCTION A a myelinated motor A alpha myelinated touch-pressure A beta myelinated touch-pressure A delta myelinated pain-temperature A gamma myelinated proprioception

  19. A Delta • 1 - 4 micrometers diameter • Myelinated, Rapid conduction • Sharp, localized • Heat, cold • “First pain”

  20. B myelinated preganglionic autonomic C non-myelinated pain-temperature

  21. C Fibers • Small • Slow Conduction • Unmyelinated • Postganglionic autonomic

  22. C Fibers • Dull pain, burning, Aching throbbing • Nonlocalized - radiating - diffused • Temperature,Touch,Mechanical • “Second pain”

  23. Gate Theory Balance between A delta and C fibers to dorsal horn determines the intensity of the stimulus that is passed to higher brain center

  24. Area of High Nociceptor Concentration • Mucosal membranes • Periosteum • Deep fascia • Ligaments • Joint capsules • Cornea • Subcutaneous tissue

  25. Areas of Moderate Nociceptor Concentration • Skeletal muscle • Cardiac muscle • Smooth muscle

  26. Areas of Minimal Nociceptor Concentration • Bone • Cartilage • Marrow

  27. Physiologic Processes of Nociception • Detection • Transduction • Transmission • Modulation • Perception

  28. Detection • “First pain” • “Second pain”

  29. TRANSDUCTION NOXIOUS STIMULI TRANSLATED INTO ELECTRICAL FIRING AT THE SENSORY NERVE ENDINGS

  30. TRANSMISSION • PROPAGATION OF IMPULSE TRAVELS VIA NEURAL PATHWAYS. • SENSORY AFFERENT NEURONS PROJECT INTO THE SPINAL CORD • ASCENDING NEURONS RELAY TO BRAINSTEM AND THALAMUS • THALAMUS RELAYS TO CEREBRAL CORTEX

  31. MODULATION INTRINIC PAIN MODIFICATION 1.DIFFERENT IN INDIVIDUALS 2.DEPENDS ON..... PAST EXPERIENCES CULTURE PSYCHIC

  32. MODULATION-CONT • STIMULUS PRODUCED ANALGESIA • NEUROENDOCRINE ANALGESIA • CNS/PNS ANALGESIA • OPIOID ANALGESIA • SITUATION • PATHOLOGY • PHYSIOLOGY

  33. Modulation – Excitatory Substances • Peripheral Prostaglandins, bradykinins, histamine, K, substance P, serotonin (5HT2) • Spinal Glutamate, aspartate, amino acids, substance P, norepinephrine (alpha 1)

  34. Modulation - Inhibitory Supraspinal • Endorphins, enkephalins, dynorphins, norepinephrine (alpha 2), GABA, somatostatin (5HT1), neurotensin

  35. First Neuron Pain Peripheral afferent fibers to dorsal horn Second Neuron Pain Dorsal horn to thalamic Third Neuron Pain Thalamus to cortex

  36. Pain Pathways: • Tissue damage>>>Algesic substanses release>>>Noxious stimuli>>>A delta and C fibers>>>to the Neuraxis>>>Many to Ant. and Anterolat.Horns>>>Segmenal reflex responses , and others via the Spinothalamic and Spinoreticular tracts>>>Suprasegmental and cortical responses.

  37. Classification & Function of Peripheral Nerve Fibers A. Myelinated A- Fibers: • a: Motor , Proprioception (afferent) • b: Motor, Touch (afferent) • g: Muscle spindles (efferent) • d: Pain, Temperature (afferent) B. Myelinated B-Fibers: • Pre-ganglionic Sympathetic Fibers C. Non-Myelinated C- Fibers: Pain, Temperature.

  38. Spinothalamic tract Dorsal horn of spinal cord • Nociceptive sensory fibres are C-fibres and Ad fibres • C-fibres umyelinated • Ad myelinated • Slow conduction velocity • Signal variety of noxious stimuli - polymodal Dorsal Root Ganglion Peripheral nerve Sympathetic ganglion Viscera Blood vessels Skeletal muscle Tendon bundle C and Ad fibres Nociceptive terminals Muscle and skin receptors Nociceptive pathways: peripheral sensory nerves

  39. Cortex Thalamus Mesencephalon Medulla oblongata Spinal cord Ascending Pain Pathways • Topographic representation maintained • Sites for pain modulation are spinal cord and thalamus Pons

  40. Segmental reflex responses: Increased skeletal muscle tone , Increased oxygen consumption , Lactic acid production • Suprasegmental • reflex responses: Increased Sympathetic tone , Hypothalamic stimulation.

  41. Chemical Mediators Membrane ion channels of Nociceptive neurons Directly coupling to membrane receptors Hydrogen ATP Serotonin 5HT3 Indirectly (more commonly) mediating intracellular secondary messages Bradykinins B1, B2 Cytokines Prostanoids Histamine H1 Serotonin 5HT1

  42. Factors that modify perioperative pain : • 1- Site ,nature and duration of surgery. • 2- Type and extent of incision. • 3- Physiologic and psychologic makeup of the patient. • 4- Pre operative preparation of the patient. • 5- Presence of complications of surgery. • 6- Anesthetic management. • 7- Quality of perioperative care. • 8- Preoperative treatment of painful stimuli .

  43. Preemptive Analgesia : • Antinociceptive treatment of that prevents the establishment of altered central prossesing, which amplifies postop. Pain. • Windup:functional changes in the dorsal horn because of pain . • This type of therapy ,in addition to reducing acute pain ,attenuates chronic postop. Pain.

  44. Principles of Pain Management Anticipate pain Recognize patient: Ask the patient Look for signs (HR, BP, facial grimacing, tears, sweating, etc) Find the source Quantify pain (mild, moderate, severe) Treat: Quantify the patients perception of pain Correct the cause where possible Give appropriate analgesics regularly as required Remember most sedative agents do not provide analgesia Reassess

  45. Modalities of Pain Relief Non-opioid analgesics+opioid analgesics Regular injections of opioids Continuous IV or SC infusion of opioids Patient controlled analgesia (PCA) Extradural opioids & or local anesthetics Combined exrtadural + spinal analgesia Long acting oral opioids Long acting regional blocks Ketamine (S+)

  46. Modalities of Pain Relief Pharmacological Non-pharmacological

  47. DRUGS NSAID’s COX-1 Minor – Moderate pain COX-2rofecoxib, parecoxib-inj Severe pain Actions: Inhibit synthesis of PG-E Direct analgesic effect on higher centers Modify nociceptive responses-bradykinins Antiplatelet Hypothrombinaemia Lowers body temp Hypoglycemia Metabolic acidosis Adverse gastrointestinal effects Lower doses only

  48. Systemic Opioids : Analgesic effects of opioids : via receptors in the CNS. Roots of administeration :I.M. ,I.V. ,Transdermal ,Oral ,Topical ,I.V. regional ,Perineural ,etc. I.M. root is the most treatment choice after surgery. The” As Needed” part of the order is often interpreted to mean “As little as possible” . No relation exists between Gender and opioid requirement.

  49. Analgesic Opiates • Morphine • Pethidine • Fentanyl • Sufentanil • Alfentanil • Remifentani • ANTIDOTE : Naloxone

  50. Routes of administration of analgesics Oral Intravenous Sublingual/buccal Epidural (opioid) Oral transmucosal Intrathecal (opiod) Intranasal Intra articular (opioid) Transdermal Topical - EMLA cream Rectal Intradermal Inhalational Peripheral N block Subcutaneous Nerve plexus block Intramuscular Intravenous regional

More Related